Summary of Significant Accounting Policies (Tables)

6 Months Ended

Sep. 30, 2019

Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Common Share

As of September 30, 2019 and 2018, potentially dilutive securities were as follows:



	September 30,
	2019	2018
Stock options	7,676,460	5,115,494
Restricted stock awards (unvested)	775,651	1,057,707
Restricted stock units (unvested)	753,720	12,500
Performance stock units (unvested)	408,510	—
Warrants	73,710	73,710
Total	9,688,051	6,259,411

Schedule of Cash, Cash Equivalents and Restricted Cash

Cash as reported on the unaudited condensed consolidated statements of cash flows includes the aggregate amounts of cash, cash equivalents, and restricted cash and consists of the following (in thousands):



	September 30,
	2019		2018
Cash and cash equivalents	$	130,373	$	153,717
Restricted cash ⁽¹⁾	1,374		600
Total cash, cash equivalents and restricted cash	$	131,747	$	154,317

⁽¹⁾ Included in other assets on the unaudited condensed consolidated balance sheets.